Navigation Links
Capitalizing in Medical News

MedAptus Customers Capitalizing on P4P Incentives via Intelligent Charge Capture

BOSTON, July 14 /PRNewswire/ -- MedAptus(R), market leader for charge capture technologies, today announced enthusiastic adoption of its P4P component across the company's Professional Intelligent Charge Capture user-base. MedAptus P4P is widely used for capture of quality measure data f...

BioInformatics, LLC New Report - Capitalizing on New Opportunities for Stem Cell Products

ARLINGTON, Va., April 7 /PRNewswire/ -- BioInformatics, LLC announces the pending release of its newest report, Capitalizing on New Opportunities for Stem Cell Products. As a result of the March 9, 2009 reversal of the 2001 restrictions on federal funding of human embryonic stem cell research,...

Drugs Manufacturers Capitalizing On The Surge In Demand For Bone Health Care

A recent survey based on an ageing population shows that bone health is set to become a major segment of the supplements and functional foods market. The lifetime risk for a woman to have an osteoporotic fracture// is 30-40 per cent and in men the risk is about 13 per cent. Yet the main natural pr...

MAP Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock

...es by applying its proprietary drug particle and inhalation technologies to enhance the therapeutic benefits of proven drugs, while minimizing risk by capitalizing on their known safety, efficacy and commercialization history. Forward-Looking Statements In addition to statements of historical fac...

AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009

...maging infrastructure solutions that support healthcare system EMR installations." Dr. Kahane went on to say, "In parallel, we are committed to capitalizing on a number of industry sub-segments that we believe provide excellent prospects for growth. We believe that AMICAS' growth will be improved by trends...

Quark Pharmaceuticals to Participate in IBC's Oligonucleotide Therapeutics: From Concept to Implementation Conference

...ging on the Promise?" It will cover the current state of development of siRNA, miRNA, antisense and aptamar therapeutics and examine how companies are capitalizing on the promise of the field. Panelists will include Paul Burke, Ph.D., Executive Director, RNA Therapeutics, Merck & Co., Inc.; Klaus Giese, Ph.D....

MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results

...es by applying its proprietary drug particle and inhalation technologies to enhance the therapeutic benefits of proven drugs, while minimizing risk by capitalizing on their known safety, efficacy and commercialization history. Additional information about MAP Pharmaceuticals can be found at http://www.map...

Rochester Medical Reports Third Quarter Results

...hange rates, the uncertainty of market acceptance of new product introductions, the uncertainty of gaining new strategic relationships or locating and capitalizing on strategic opportunities, the uncertainty of timing of private label sales revenues (particularly international customers), FDA and other regulatory...

LCA-Vision Reports Second Quarter Financial Results

...eek, joining the International Health, Racquet & Sportsclub Association, or IHRSA, as an associate member with its 9,750 member facilities, and by capitalizing on our relationships with health and vision plans that reduce the out-of-pocket cost to the patient - a leading factor in the decision-making process....

aTyr Pharma Raises an Additional $12 Million

...cision to have an Asian presence for aTyr Pharma was driven by our recognition of the progress China has made in meeting international standards while capitalizing on government support for building biotechnology in China. Pangu BioPharma has already identified multiple resectins for our discovery engine, increa...
Capitalizing in Medical Technology

BioInformatics, LLC New Report - Capitalizing on New Opportunities for Stem Cell Products, Now Available

ARLINGTON, Va., May 5 /PRNewswire/ -- BioInformatics, LLC announces the release of its newest report, Capitalizing on New Opportunities for Stem Cell Products. Despite a sluggish economy and cuts being made to laboratory budgets, the market for stem cell research products is expected to increa...

MAP Pharmaceuticals Announces Phase 3 Study of Unit Dose Budesonide in Children With Asthma Did Not Meet Primary Endpoints

...s by applying its proprietary drug particle and inhalation technologies to enhance the therapeutic benefits of proven drugs, while minimizing risk, by capitalizing on their known safety, efficacy and commercialization history. Additional information about MAP Pharmaceuticals can be found at http://www.ma...

AstraZeneca's Partner, MAP Pharmaceuticals, Announces Phase 3 Study of Unit Dose Budesonide in Children with Asthma Did Not Meet Primary Endpoints

...s by applying its proprietary drug particle and inhalation technologies to enhance the therapeutic benefits of proven drugs, while minimizing risk, by capitalizing on their known safety, efficacy and commercialization history. Additional information about MAP Pharmaceuticals can be found at http://www.mapp...

PLC Systems Defers Pivotal Study of RenalGuard(TM) in the U.S.

...ond our focus on the CIN market in 2009, with a CE Mark in hand we plan to focus on several new applications for RenalGuard in the European Union (EU) capitalizing on the automated fluid balancing capabilities of our system. Specifically, there are several medical applications, such as cisplatin chemotherapy, whe...

MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion

...ies its proprietary inhalation technologies to enhance the therapeutic benefits and commercial attractiveness of proven drugs while minimizing risk by capitalizing on their known safety, efficacy and commercialization history. MAP Pharmaceuticals has two drug candidates in Phase 3 clinical trials. Unit Dose Budes...

MAP Pharmaceuticals Initiates Phase 3 Clinical Trial in Patients With Migraine

...ies its proprietary inhalation technologies to enhance the therapeutic benefits and commercial attractiveness of proven drugs while minimizing risk by capitalizing on their known safety, efficacy and commercialization history. MAP Pharmaceuticals has two drug candidates in Phase 3 clinical trials. Unit Dose Budes...

MAP Pharmaceuticals Reports Positive Pharmacological Response Data for Migraine Product Candidate at the American Headache Society Annual Meeting

...ies its proprietary inhalation technologies to enhance the therapeutic benefits and commercial attractiveness of proven drugs while minimizing risk by capitalizing on their known safety, efficacy and commercialization history. MAP Pharmaceuticals has two drug candidates, Unit Dose Budesonide and MAP0004, in late ...

MAP Pharmaceuticals Reports Positive Results From Phase 2a Clinical Trial of Combination Therapy in Adult Asthmatics

...ies its proprietary inhalation technologies to enhance the therapeutic benefits and commercial attractiveness of proven drugs while minimizing risk by capitalizing on their known safety, efficacy and commercialization history. MAP Pharmaceuticals has two drug candidates, Unit Dose Budesonide and MAP0004, in late ...

MAP Pharmaceuticals Reports Positive Results From Comparative Pharmacokinetic Trial for its Pediatric Asthma Product Candidate

...ies its proprietary inhalation technologies to enhance the therapeutic benefits and commercial attractiveness of proven drugs while minimizing risk by capitalizing on their known safety, efficacy and commercialization history. MAP Pharmaceuticals has two drug candidates, Unit Dose Budesonide and MAP0004, in late ...

The Quigley Corporation Reports Third Quarter Results, Increases Investment in Pharmaceutical R&D for Diabetic Neuropathy

...ng loss carry-forward position. The research by the Company is part of its strategic initiatives to generate future growth. These initiatives include capitalizing on the growth potential of Quigley Pharma, a wholly-owned Ethical Pharmaceutical subsidiary, by developing natural-source potential prescription produ...
Capitalizing in Medical Products

Mx8000 Dual

Description:...ications. Applications that grow your practice such as CT angiography, gated cardiac studies, functional CT, and true submillimeter isotropic imaging. capitalizing on proven technology from across the Mx8000 family, including the Mx8000 IDT and MxViewexp, the Mx8000 Dual offers a premium workstation and multislic...
Company:Philips Medical Systems
Capitalizing in Biological News

New MRI technique could mean fewer breast biopsies in high-risk women

...dimensional images necessary for such a diagnosis, Block, UW-Madison radiology associate professor Fred Kelcz and graduate student Catherine Moran are capitalizing on their unique MRI data-acquisition method. An MR image is made up of thousands of smaller pieces of information. The conventional data-acquisiti...

Supply-Chain Council Announces Winners of 2009 Supply Chain Excellence Awards

... related operations within their company or against other companies. SCC continually advances its tools and educates sponsors about how companies are capitalizing on those tools. For information, visit www.SCORlabs.org , or www.supply-chain.org ; call +1 202-540 8030; or e-mail info@supply-chain.org " targe...

Ma and Pa solutions to global warming

... The prairies offer opportunities for capitalizing on environmentally friendly farming practices and potentially useful agricultural waste to produce jobs, economic growth, commercial opportunities, an...

Study reveals effects of unconscious exposure to advertisements

...s the form of apparel branded with company's names, and products strategically placed in movies and television shows, often go unnoticed by consumers, capitalizing on our brain's mechanisms to modulate preference based on non-conscious exposure. Changizi's research suggests that such advertising tactics work b...

BIO-key(R) Reports Profitability on Strong Revenue Growth for Second Quarter 2008

...ment, have enabled us achieve our major operating objective -- profitable growth. With the achievement of this objective, management is now focused on capitalizing on this momentum to achieve sustainable and growing profitability and revenue. We believe the marketing and technology strategies we have developed an...

BIO-key(R) Reports Profitability on Strong Revenue Growth for Second Quarter 2008

...ment, have enabled us achieve our major operating objective -- profitable growth. With the achievement of this objective, management is now focused on capitalizing on this momentum to achieve sustainable and growing profitability and revenue. We believe the marketing and technology strategies we have developed an...

Compost can turn agricultural soils into a carbon sink, thus protecting against climate change

...y of soils, better water retention, less production and use of mineral fertilizers and pesticides, and reduced release of nitrous oxide. However, capitalizing on this potential climate-change mitigation measure is not a simple task. The issue is complicated by the fact that industrial farming techniques mean...

IEEE-USA innovation forum will help prepare US tech leaders to prosper in a global marketplace

... Large vs. small organizations as foundations for innovation The innovation process and how to leverage your style to promote innovation capitalizing on new technologies and processes The event begins on 6 November with an opening night reception and dinner. The forum starts the next day with a...

Scientists reveal how deadly toxin hijacks cells

...engers, known as neurotransmitters, that communicate with muscles. When enough nerve endings are invaded, botox can lead to paralysis and death. By capitalizing on the ability of botox to act on a localized group of muscles, doctors have strategically used the toxin to treat an array of medical troubles, inclu...

Scientists closer to new cancer detection method

...titute. "This approach could help for early diagnosis of cancer, as well as for detecting residual cancer in patients after treatment." It works by capitalizing on fluorescent molecules engineered into tiny strands of DNA or RNA. Known as aptamers, the strands act as molecular beacons, corresponding and readil...
Capitalizing in Biological Technology

New MRI technique could mean fewer breast biopsies in high-risk women

...dimensional images necessary for such a diagnosis, Block, UW-Madison radiology associate professor Fred Kelcz and graduate student Catherine Moran are capitalizing on their unique MRI data-acquisition method. An MR image is made up of thousands of smaller pieces of information. The conventional data-acquisiti...

BioStorage Technologies Takes Lead Sponsorship Role of 2nd Annual IIR Biorepositories Conference

...y samples through proper collection and storage practices; facilitating the creation of standards to build a level of consistency across the industry; capitalizing on biorepositories as a strategic asset for translational medicine; implementing ethical and informed consent practices to optimize sample usage; an...

Accumetrics, Inc. Announces European Distribution Channels for France, Austria, Switzerland, Netherlands, Belgium and Luxembourg

...enotyping for anti-coagulation therapy. With a panel of varied products and services, the company focuses on health professionals and patients alike, capitalizing on the emerging interest in anti-coagulation therapy monitoring of patients in decentralized settings and near-patient testing in France. A b ...

As Other States Pull Back, Kansas Accelerates Innovation Investments at Bio International Convention

...the practice of orthopedic medicine. The center will focus on commercial viability, conducting research requested by industry to meet market needs and capitalizing on the concentration of composites expertise found in Wichita due to the state's longstanding aviation industry leadership. Partnering to form th...

Medarex Announces 2009 First Quarter Financial Results

...e given us a strong start to an exciting year," said Howard H. Pien, Chairman and CEO of Medarex. "In addition to furthering our pipeline, we are also capitalizing on value-creating opportunities, including our agreement with Merck and the progress and recent approvals for products developed by licensee partners....

Human Genome Sciences Announces First Quarter 2009 Financial Results and Key Developments

...S. "Our revenues were up substantially and were driven for the first time by product sales. We reduced our long-term debt by more than 20 percent by capitalizing on an opportunity to repurchase $106 million of our outstanding convertible notes at reasonable prices. Our cash position was strengthened and contin...

Publication of Shire plc's Annual Report 2008

...time. We are moving forward-bolstering our pipeline through business-enhancing acquisitions, anticipating breakthroughs for patients with unmet needs, capitalizing on new patient populations, and looking for commonalities between our Specialty and HGT businesses. It's been an exciting time and the future promises...

aTyr Pharma to Present at ChinaBio(R) Investor Forum in Hong Kong

...ma have a novel platform of naturally occurring protein fragments that can be developed into biologic agents for treating a wide variety of diseases. capitalizing on the years of experience and discoveries made by founder Prof. Paul Schimmel, aTyr Pharma and Pangu BioPharma are identifying a broad platform of pr...

Dr. James Cai Joins aTyr Pharma to Drive Clinical Development in Asia

...arma are discovering novel, naturally occurring protein fragments that can be developed into biologic agents for treating a wide variety of diseases. capitalizing on the years of experience and discoveries made by founder Prof. Paul Schimmel, aTyr Pharma and Pangu BioPharma are identifying a broad platform of pr...

Biomerix Corporation Announces FDA Clearance and Market Launch of REVIVE(TM) for Use in Soft Tissue Repair Procedures

...is poised for rapid growth over the course of the next few years. The company plans to launch numerous products across a range of therapeutic areas by capitalizing on its novel Biomerix Biomaterial platform technology. REVIVE is specifically designed to support tissue remodeling by enhancing the soft tissue woun...
Capitalizing in Biological Definition

Stem cell

...lude: StemCells Inc. and Aastrom Biosciences. Others are reluctant to enter the market because they fear government restrictions preventing them from capitalizing on the research. However, individual medical treatments are being financed by private research groups such as pharmaceutical and biotechnology compan...
Other Tags
(Date:8/4/2015)... ... August 04, 2015 , ... ... Text results have been impressive so far". , Mr Cauchois attributes the ... Winscribe's French sales partner Dicma and the healthcare technology offered by Winscribe's platform. ...
(Date:8/3/2015)... ... 2015 , ... While the pace of the economic recovery since the 2008 has been subject ... growth trajectory for the last six years. Unemployment has dropped from a 2009 high of ... percent growth rate in 2014, the U.S. stock market is at an all time high, ...
(Date:8/3/2015)... ... August 03, 2015 , ... Zeiter’s Septic ... As a family owned and operated business, Zeiter’s Septic has been serving the ... leader in septic installations because of their continued training and perseverance to provide ...
(Date:8/3/2015)... ... 2015 , ... Code , an industry leader of image-based barcode reading ... Reader accessory that enables a wireless connection between the CR5000 and a ... of barcode reading applications with iPads, Galaxy Tabs, and many other products that lack ...
(Date:8/3/2015)... ... August 03, 2015 , ... Bayer has agreed to pay ... claims in which a claimant alleged to have suffered an arterial blood clot including ... control pills, Yaz, Yasmin and Ocella, has been ongoing for well-over five years. In ...
Breaking Medicine News(10 mins):Health News:The Oscar Lambret Center (France) Completes First Stage Of Winscribe Text Rollout 2Health News:The Oscar Lambret Center (France) Completes First Stage Of Winscribe Text Rollout 3Health News:The Oscar Lambret Center (France) Completes First Stage Of Winscribe Text Rollout 4Health News:Newport Board group, an Advisory Firm Serving the Middle Market, Cautions Businesses on How to Survive the Coming Recession 2Health News:Newport Board group, an Advisory Firm Serving the Middle Market, Cautions Businesses on How to Survive the Coming Recession 3Health News:Newport Board group, an Advisory Firm Serving the Middle Market, Cautions Businesses on How to Survive the Coming Recession 4Health News:Zeiter’s Septics Performs Affordable Septic Installations Throughout Livingston & Putnam Counties Effective Immediately 2Health News:Zeiter’s Septics Performs Affordable Septic Installations Throughout Livingston & Putnam Counties Effective Immediately 3Health News:Code Launches the T500, an Innovative Code Reader Accessory 2Health News:Code Launches the T500, an Innovative Code Reader Accessory 3Health News:Bayer Agrees To Settle Yaz Aterial Blood Clot Lawsuits 2
(Date:7/13/2015)... 13, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... company focused on the growing mobile commerce market, ... 62/188684 for BEHAVIORAL-DIRECTED AUTHENTIATION METHOD AND ... and secure method to make payments.  With this ... introduced with its groundbreaking voice-direct payment patent application, ...
(Date:7/9/2015)... , July 9, 2015  Synaptics Inc. ... of human interface solutions, today announced a ... first fully hardware encapsulated fingerprint sensor and ... technology is literally off the grid, isolating ... matching within the fingerprint sensor to provide ...
(Date:7/8/2015)... The consumer products industry for innovative ... products such as wearables, smart wallets & other smart technology ... devices continues to rapidly grow.  Biometrics & Wearable Device Companies ... Google Inc. (NASDAQ: GOOG ), Apple Inc. (NASDAQ: ... (NASDAQ: GPRO ) and Baidu Inc. (NASDAQ: BIDU ...
Breaking Biology News(10 mins):NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 3Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 2Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 3Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 4Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 5Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 6
Other Contents